A name of Samsung Biologics Co. is displayed at the Korea Exchange in Seoul, South Korea, Thursday, Nov. 10, 2016. Samsung Biologics Co., the contract drug making unit of Samsung Group, made its market debut in Seoul on Thursday in South Korea's largest initial public offering in six years. (AP Photo/Lee Jin-man)
Rookie QB Daniels stars again in desert return, Commanders beat Cardinals 42-14 for 3rd straight Shares
Rescuers race to free people trapped by Hurricane Helene after storm kills at least 40 in 4 states Shares